12 Recruiting Gastric Cancer Phase 1 Clinical Trials
Active phase 1 studies for gastric cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Gastric Cancer studiesPhase 1 Studies for Gastric Cancer
🔵 Active, Not Recruiting Phase1
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
📍 Mayo Clinic — Scottsdale, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
📍 USC Norris Comp. Cancer Ctr Hospital — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer
📍 Johns Hopkins University — Baltimore, Maryland
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Study for AZD4360 in Participants With Advanced Solid Tumours
📍 Research Site — Santa Monica, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
📍 Research Site — Jacksonville, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
📍 University of Kansas Cancer Center — Westwood, Kansas
View Study & Checklist ➔ 🟢 Recruiting Phase1
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
📍 Rutgers Cancer Institute — New Brunswick, New Jersey
View Study & Checklist ➔ 🟢 Recruiting Phase1
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
📍 NEXT Virginia — Fairfax, Virginia
View Study & Checklist ➔ 🟢 Recruiting Phase1
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
📍 Stanford Cancer Center — Palo Alto, California
View Study & Checklist ➔